SAN DIEGO, Aug. 30, 2017 /PRNewswire/ -- NuVasive, Inc.
(NASDAQ: NUVA), a leading medical device company focused on
transforming spine surgery with minimally disruptive,
procedurally-integrated solutions, today announced that management
will participate in the following investor events in September 2017:
- Wells Fargo Healthcare Conference at The Westin Boston
Waterfront in Boston on
Thursday, Sept. 7, 2017 at
2:15 p.m. ET / 11:15 a.m. PT; and
- Morgan Stanley 15th Annual Global Healthcare Conference at the
Grand Hyatt New York in New York
on Wednesday, Sept. 13, 2017 at
9:20 a.m. ET / 6:20 a.m. PT.
A live webcast of the presentations will be available online
from the Investor Relations page of the Company's website at
nuvasive.com. A replay of the presentations will remain available
on the website for 30 days after the applicable live webcast.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is transforming spine surgery and
beyond with minimally invasive, procedurally-integrated solutions
designed to deliver reproducible and clinically-proven surgical
outcomes. The Company's portfolio includes access instruments,
implantable hardware, biologics, software systems for surgical
planning, navigation and imaging solutions, magnetically adjustable
implant systems for spine and orthopedics, and intraoperative
monitoring service offerings. With $962
million in revenues (2016), NuVasive has an approximate
2,300 person workforce in more than 40 countries serving surgeons,
hospitals and patients. For more information, please visit
www.nuvasive.com.
Forward-Looking Statements
NuVasive cautions you that statements included in this news
release that are not a description of historical facts are
forward-looking statements that involve risks, uncertainties,
assumptions and other factors which, if they do not materialize or
prove correct, could cause NuVasive's results to differ materially
from historical results or those expressed or implied by such
forward-looking statements. The potential risks and uncertainties
which contribute to the uncertain nature of these statements
include, among others, risks associated with acceptance of the
Company's surgical products and procedures by spine surgeons,
development and acceptance of new products or product enhancements,
clinical and statistical verification of the benefits achieved via
the use of NuVasive's products (including the iGA™ platform), the
Company's ability to effectually manage inventory as it continues
to release new products, its ability to recruit and retain
management and key personnel, and the other risks and uncertainties
described in NuVasive's news releases and periodic filings with the
Securities and Exchange Commission. NuVasive's public filings with
the Securities and Exchange Commission are available at
www.sec.gov. NuVasive assumes no obligation to update any
forward-looking statement to reflect events or circumstances
arising after the date on which it was made.
View original content with
multimedia:http://www.prnewswire.com/news-releases/nuvasive-to-participate-in-investor-events-in-september-2017-300510993.html
SOURCE NuVasive, Inc.